Nuvalent (NUVL) Enterprise Value (2020 - 2026)
Nuvalent (NUVL) reported Enterprise Value of -$1.3 billion for Q1 2026, down 19.96% on a YoY basis from -$1.6 billion in Q1 2025, and up 6.16% quarter-over-quarter from -$1.4 billion in Q4 2025.
Nuvalent (NUVL) Enterprise Value (2020 - 2026) Analysis & Trends
Nuvalent has reported Enterprise Value for 7 years, with the latest figure at -$1.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 19.96% year-over-year to -$1.3 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.3 billion (down 19.96% YoY), and the FY2025 full-year result was -$1.4 billion, down 22.68% from the prior year.
- Enterprise Value for Q1 2026 stood at -$1.3 billion, up from -$1.4 billion in the prior quarter.
- The five-year high for Enterprise Value was -$240.1 million in Q3 2022, with the low at -$1.4 billion in Q4 2025.
- Historically, Enterprise Value has averaged -$739.7 million across 5 years, with a median of -$691.8 million in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value climbed 20.62% — and 2024, when it tumbled 182.71%.
- Nuvalent's Enterprise Value stood at -$472.2 million in 2022, then slumped by 52.47% to -$719.9 million in 2023, then plunged by 55.34% to -$1.1 billion in 2024, then declined by 22.68% to -$1.4 billion in 2025, then gained by 6.16% to -$1.3 billion in 2026.
- The last three Enterprise Value figures came in at -$1.3 billion (Q1 2026), -$1.4 billion (Q4 2025), and -$943.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | Nuvalent | 9.70 Bn | 9.70 Bn | - | -1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 Bn |
| Dec 31, 2025 | -1.37 Bn |
| Sep 30, 2025 | -943.10 Mn |
| Jun 30, 2025 | -1.01 Bn |
| Mar 31, 2025 | -1.07 Bn |
| Dec 31, 2024 | -1.12 Bn |
| Sep 30, 2024 | -1.17 Bn |
| Jun 30, 2024 | -657.99 Mn |
| Mar 31, 2024 | -691.84 Mn |
| Dec 31, 2023 | -719.91 Mn |
| Sep 30, 2023 | -413.26 Mn |
| Jun 30, 2023 | -431.24 Mn |
| Mar 31, 2023 | -450.46 Mn |
| Dec 31, 2022 | -472.16 Mn |
| Sep 30, 2022 | -240.06 Mn |
| Jun 30, 2022 | -256.96 Mn |
| Mar 31, 2022 | -272.73 Mn |
| Dec 31, 2021 | -288.11 Mn |
| Sep 30, 2021 | -302.43 Mn |
| Dec 31, 2020 | -10.33 Mn |